The FDA has approved Ketarx, a ketamine-based drug developed by drugmaker PharmaTher, for use in pain management. The medication is now cleared by the FDA for clinical use in perioperative settings, marking a key development in the medical application of…
Pharmacy
Drugmaker Sun Pharma pledged sweeping reforms after years of persistent safety violations at its flagship manufacturing plant in Halol, India, but failed to follow through, according to FDA documents obtained by ProPublica. The documents also showed the FDA tolerated repeated…
A large-scale cohort study has found that GLP-1s, including Ozempic and Wegovy, may be associated with a modestly increased risk of developing diabetic retinopathy. The research, published Aug. 11 in JAMA Network Open, analyzed data from over 185,000 individuals with…
A study has found that prescribing semaglutide in everyday clinical settings led to modest but meaningful improvements in cardiovascular risk alongside a rise in non-drug healthcare costs. The study, published Aug. 8 in JAMA Network Open, analyzed data from more…
Vinay Prasad, MD, former head of the FDA’s vaccine and gene therapy division who resigned under political pressure two weeks ago, is returning to the agency, The New York Times reported Aug. 9. Dr. Prasad stepped down from the role…
Advertisement
AHA, along with other national hospital groups, urged the Health Resources and Services Administration to extend key deadlines for its recently announced 340B rebate model pilot program. In a joint letter issued Aug. 8, the groups said the agency’s current…
The FDA has lifted its previously recommended pause on the use of the Chikungunya virus vaccine in individuals 60 and older, following a benefit-risk assessment. The agency also approved updated labeling for the vaccine, which includes expanded warnings about adverse…
GSK said it will receive $370 million as part of the U.S. patent settlement involving CureVac and BioNTech over mRNA-based COVID-19 vaccines, The Wall Street Journal reported Aug. 8. Under the deal, GSK will receive a $320 million cash payment.…
The American Society of Health-System Pharmacists has named Kim Benner, PharmD, as the organization’s next president. Dr. Benner is a professor at Samford University’s pharmacy school in Birmingham, Ala., and a pediatric clinical pharmacy specialist at Children’s of Alabama in…
A growing number of health systems are investing heavily in centralized service centers to help reduce costs, address drug shortages and streamline operations.